These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 7862893)

  • 1. The nicotinic antagonist mecamylamine precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Hebert KM; Conrad DL; Wilson OB
    Psychopharmacology (Berl); 1994 Jun; 115(1-2):180-4. PubMed ID: 7862893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The nitric oxide synthesis inhibitor nitro-L-arginine (L-NNA) attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Shenoi M; Upchurch TP; Johnson SC; Schweinle WE; Cadle CD
    Psychopharmacology (Berl); 1998 Dec; 140(3):371-7. PubMed ID: 9877017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone precipitates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Carter VA; Cunningham JS; Wilson OB
    Psychopharmacology (Berl); 1993; 112(2-3):339-42. PubMed ID: 7871039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bupropion attenuates nicotine abstinence syndrome in the rat.
    Malin DH; Lake JR; Smith TD; Khambati HN; Meyers-Paal RL; Montellano AL; Jennings RE; Erwin DS; Presley SE; Perales BA
    Psychopharmacology (Berl); 2006 Mar; 184(3-4):494-503. PubMed ID: 16163521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nicotine abstinence syndrome precipitated by the competitive nicotinic antagonist dihydro-beta-erythroidine.
    Malin DH; Lake JR; Upchurch TP; Shenoi M; Rajan N; Schweinle WE
    Pharmacol Biochem Behav; 1998 Jul; 60(3):609-13. PubMed ID: 9678643
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mecamylamine-precipitated nicotine-withdrawal aversion in rats.
    Suzuki T; Ise Y; Tsuda M; Maeda J; Misawa M
    Eur J Pharmacol; 1996 Oct; 314(3):281-4. PubMed ID: 8957247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rodent model of nicotine abstinence syndrome.
    Malin DH; Lake JR; Newlin-Maultsby P; Roberts LK; Lanier JG; Carter VA; Cunningham JS; Wilson OB
    Pharmacol Biochem Behav; 1992 Nov; 43(3):779-84. PubMed ID: 1448472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Behavioral manifestations of the nicotine abstinence syndrome in the rat: peripheral versus central mechanisms.
    Hildebrand BE; Nomikos GG; Bondjers C; Nisell M; Svensson TH
    Psychopharmacology (Berl); 1997 Feb; 129(4):348-56. PubMed ID: 9085404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissociation of physical abstinence signs from changes in extracellular dopamine in the nucleus accumbens and in the prefrontal cortex of nicotine dependent rats.
    Carboni E; Bortone L; Giua C; Di Chiara G
    Drug Alcohol Depend; 2000 Feb; 58(1-2):93-102. PubMed ID: 10669059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nicotine abstinence syndrome precipitated by central but not peripheral hexamethonium.
    Malin DH; Lake JR; Schopen CK; Kirk JW; Sailer EE; Lawless BA; Upchurch TP; Shenoi M; Rajan N
    Pharmacol Biochem Behav; 1997 Nov; 58(3):695-9. PubMed ID: 9329061
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine withdrawal in adolescent and adult rats.
    O'Dell LE; Bruijnzeel AW; Ghozland S; Markou A; Koob GF
    Ann N Y Acad Sci; 2004 Jun; 1021():167-74. PubMed ID: 15251887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral and biochemical manifestations of mecamylamine-precipitated nicotine withdrawal in the rat: role of nicotinic receptors in the ventral tegmental area.
    Hildebrand BE; Panagis G; Svensson TH; Nomikos GG
    Neuropsychopharmacology; 1999 Oct; 21(4):560-74. PubMed ID: 10481840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Selective c-fos induction and decreased dopamine release in the central nucleus of amygdala in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Panagis G; Hildebrand BE; Svensson TH; Nomikos GG
    Synapse; 2000 Jan; 35(1):15-25. PubMed ID: 10579804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible.
    Malin DH; Lake JR; Payne MC; Short PE; Carter VA; Cunningham JS; Wilson OB
    Pharmacol Biochem Behav; 1996 Jan; 53(1):81-5. PubMed ID: 8848464
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monoamine oxidase inhibition dramatically prolongs the duration of nicotine withdrawal-induced place aversion.
    Guillem K; Vouillac C; Koob GF; Cador M; Stinus L
    Biol Psychiatry; 2008 Jan; 63(2):158-63. PubMed ID: 17643399
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome.
    Hildebrand BE; Nomikos GG; Hertel P; Schilström B; Svensson TH
    Brain Res; 1998 Jan; 779(1-2):214-25. PubMed ID: 9473676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nicotine abstinence in the mouse.
    Isola R; Vogelsberg V; Wemlinger TA; Neff NH; Hadjiconstantinou M
    Brain Res; 1999 Dec; 850(1-2):189-96. PubMed ID: 10629764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats.
    Paterson NE; Markou A
    Psychopharmacology (Berl); 2004 Apr; 173(1-2):64-72. PubMed ID: 14712336
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of mecamylamine-precipitated nicotine-withdrawal aversion by the 5-HT3 receptor antagonist ondansetron.
    Suzuki T; Ise Y; Mori T; Misawa M
    Life Sci; 1997; 61(16):PL249-54. PubMed ID: 9353175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A rodent model of cocaine abstinence syndrome.
    Malin DH; Moon WD; Moy ET; Jennings RE; Moy DM; Warner RL; Wilson OB
    Pharmacol Biochem Behav; 2000 Jun; 66(2):323-8. PubMed ID: 10880685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.